03:36 PM EST, 11/19/2025 (MT Newswires) -- Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index easing 0.2% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.3%.

The iShares Biotechnology ETF (IBB) shed 0.6%.

In corporate news, Johnson & Johnson's ( JNJ ) Janssen Biotech unit has been granted traditional approval to Darzalex Faspro with bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed light chain amyloidosis, the US Food and Drug Administration said Wednesday. Johnson & Johnson ( JNJ ) shares rose 1.4%.